MEGAN BECKER: Open Payments
NPI 1073183844 · BLOOMINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 52 payments from 11 companies in 2025. Trend: 2023 $1,327 · 2024 $2,663 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $515 |
| Ipsen Biopharmaceuticals, Inc | 6 | $121 |
| Otsuka America Pharmaceutical, Inc. | 3 | $86 |
| Janssen Biotech, Inc. | 2 | $71 |
| Daiichi Sankyo Inc. | 1 | $33 |
| GENZYME CORPORATION | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| VIVUS LLC | 1 | $18 |
| Celltrion USA Inc. | 1 | $17 |
Products named: SKYRIZI, IQIRVO, RINVOQ, REXULTI, TREMFYA, CREON, LINZESS, INJECTAFER.
Industry payments across IL — which companies pay providers there.
